finance.foundation / Companies / ABBV vs ROG
Comparison · seed-0.6 · 2026-08-29
AbbVie (ABBV) vs Roche (ROG)
AbbVie (ABBV) and Roche (ROG) side by side: both in Healthcare, listed on New York Stock Exchange and SIX Swiss Exchange. AbbVie is the larger of the two by approximate market capitalization (about 1.5×).
| Field | AbbVie | Roche |
|---|---|---|
| Legal name | AbbVie Inc. | Roche Holding AG |
| Ticker | ABBV | ROG |
| Exchange | New York Stock Exchange XNYS | SIX Swiss Exchange XSWX |
| Jurisdiction | United States | Switzerland |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceuticals | Pharmaceuticals and diagnostics |
| Market cap ≈ | $390bn | $260bn |
| Founded | 2013 | 1896 |
| Reporting currency | USD | CHF |
| LEI | FR5LCKFTG8054YNNRU85 | 549300U41AUUVOAAOB37 |
| ISIN | US00287Y1091 | CH0012032048 |
| FIGI | BBG0025Y4RZ3 | BBG001SD12S2 |
| Index membership | S&P 500 | — |
| Held by (covered funds) | — | — |
AbbVie
Large pharmaceutical company spun off from Abbott in 2013, with immunology blockbusters Skyrizi and Rinvoq succeeding Humira, plus the Allergan aesthetics portfolio (Botox).
Roche
Basel-based healthcare group founded in 1896, the world leader in in-vitro diagnostics and a top oncology drugmaker. The founding Hoffmann and Oeri families still hold a controlling voting stake.
Approximate reference values (seed-0.6 · 2026-08-29) — not real-time, not investment advice. Both sides as data: /api/v1/companies/abbvie · /api/v1/companies/roche